Literature DB >> 26119064

Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics.

Montserrat Baldan-Martin1, Fernando de la Cuesta1, Gloria Alvarez-Llamas2, Laura Gonzalez-Calero2, Gema Ruiz-Hurtado3, Rafael Moreno-Luna1, Laura Mourino-Alvarez1, Tamara Sastre-Oliva1, Julian Segura4, Luis R Padial5, Fernando Vivanco6, Luis M Ruilope7, Maria G Barderas1.   

Abstract

BACKGROUND: High albuminuria is a strong predictor of development of cardiovascular events in hypertensive patients. The search for predictors identifying patients at risk of developing high albuminuria or presenting a more rapid progression in this parameter may represent an effective strategy for adequate intervention and better outcome. METHODS AND
RESULTS: Initially we investigated 24 patients presenting with normoalbuminuria, de novo albuminuria and sustained albuminuria. Plasma proteomics disclosed an upregulation of ceruloplasmin (CP), haptoglobin (HP) and alpha 1-acid glycoprotein (ORM1) that in a second step were selected for validation using turbidimetry assay in a cohort of 105 subjects. The validation showed that HP and ORM1 proteins were increased in patients presenting with very high albuminuria and potential irreversible kidney damage. CP and HP correlated positively with albuminuria values in normoalbuminuric patients. Finally, the levels of ORM1 and CP were increased in patients who progressed in their levels of albuminuria.
CONCLUSIONS: Our findings show that these proteins may potentially be useful for predicting the development of high albuminuria and to monitor renal damage.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Albuminuria; Hypertension; Organ damage; Plasma proteomics; RAS suppression

Mesh:

Substances:

Year:  2015        PMID: 26119064     DOI: 10.1016/j.ijcard.2015.05.148

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Progression of Renal Insufficiency in Patients with Essential Hypertension Treated with Renin Angiotensin Aldosterone System Blockers: An Electrocardiographic Correlation.

Authors:  Luis Rodriguez-Padial; Finn Akerström; María G Barderas; Fernando Vivanco; Miguel A Arias; Julian Segura; Luis M Ruilope
Journal:  Diseases       Date:  2017-12-08

2.  Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria.

Authors:  Fernando de la Cuesta; Montserrat Baldan-Martin; Rafael Moreno-Luna; Gloria Alvarez-Llamas; Laura Gonzalez-Calero; Laura Mourino-Alvarez; Tamara Sastre-Oliva; Juan A López; Jesús Vázquez; Gema Ruiz-Hurtado; Julian Segura; Fernando Vivanco; Luis M Ruilope; Maria G Barderas
Journal:  Oncotarget       Date:  2017-02-28

3.  Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.

Authors:  Laura Gonzalez-Calero; Paula J Martínez; Marta Martin-Lorenzo; Montserrat Baldan-Martin; Gema Ruiz-Hurtado; Fernando de la Cuesta; Eva Calvo; Julian Segura; Juan Antonio Lopez; Jesús Vázquez; Maria G Barderas; Luis M Ruilope; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  Oncotarget       Date:  2017-07-04

4.  Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Authors:  Montserrat Baldan-Martin; Juan A Lopez; Nerea Corbacho-Alonso; Paula J Martinez; Elena Rodriguez-Sanchez; Laura Mourino-Alvarez; Tamara Sastre-Oliva; Tatiana Martin-Rojas; Raul Rincón; Eva Calvo; Jesus Vazquez; Fernando Vivanco; Luis R Padial; Gloria Alvarez-Llamas; Gema Ruiz-Hurtado; Luis M Ruilope; Maria G Barderas
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.